The dosage dependence of VEGF stimulation on scaffold neovascularisation

Biomaterials

Volumn 29, Issue 26, 2008, Pages 3531-3538

  Davies, Neil ^a   Dobner, Stephan ^a   Bezuidenhout, Deon ^a   Schmidt, Christian ^a   Beck, Michael ^b   Zisch, Andreas H ^c,d,e   Zilla, Peter ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b MEDTRONIC INC   (United States)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e ETH ZURICH   (Switzerland)

Author keywords

Angiogenesis; Polyurethane; Scaffolds; Tissue regeneration; Vascular endothelial growth factor; Vessel regression

Indexed keywords

GROWTH FACTORS; POLYMERIC SCAFFOLDS; POLYURETHANE SCAFFOLDS; POROUS SCAFFOLDS; TISSUE REGENERATION; VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF); VASCULARISATION;

LECTIN; SCAFFOLD PROTEIN; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CELL TRANSFORMATION; HUMAN; HUMAN CELL; OSMOTIC PUMP; PERFUSION; PERICYTE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ANIMALS; BLOOD VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; NEOVASCULARIZATION, PHYSIOLOGIC; TISSUE ENGINEERING; TISSUE SCAFFOLDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 46349099663     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2008.05.007     Document Type: Article

References (25)

1. Sands R.W., and Mooney D.J. Polymers to direct cell fate by controlling the microenvironment. Curr Opin Biotechnol 18 5 (2007) 448-453
2. Elcin A.E., and Elcin Y.M. Localized angiogenesis induced by human vascular endothelial growth factor-activated PLGA sponge. Tissue Eng 12 4 (2006) 959-968
3. Smith M.K., Peters M.C., Richardson T.P., Garbern J.C., and Mooney D.J. Locally enhanced angiogenesis promotes transplanted cell survival. Tissue Eng 10 1-2 (2004) 63-71
4. Laschke M.W., Harder Y., Amon M., Martin I., Farhadi J., Ring A., et al. Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes. Tissue Eng 12 8 (2006) 2093-2104
5. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 6 4 (2000) 389-395
6. Yancopoulos G., Davis S., Gale N., Rudge J., Wiegand S., and Holash J. Vascular-specific growth factors and blood vessel formation. Nature 407 6801 (2000) 242-248
7. Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nat Med 9 6 (2003) 669-676
8. Takeshita S., Zheng L.P., Brogi E., Kearney M., Pu L.Q., Bunting S., et al. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest 93 2 (1994) 662-670
9. Zisch A.H., Lutolf M.P., and Hubbell J.A. Biopolymeric delivery matrices for angiogenic growth factors. Cardiovasc Pathol 12 6 (2003) 295-310
10. Richardson T., Peters M., Ennett A., and Mooney D. Polymeric system for dual growth factor delivery. Nat Biotechnol 19 11 (2001) 1029-1034
11. Zisch A.H., Lutolf M.P., Ehrbar M., Raeber G.P., Rizzi S.C., Davies N., et al. Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth. FASEB J 17 15 (2003) 2260-2262
12. Dor Y., Djonov V., Abramovitch R., Itin A., Fishman G.I., Carmeliet P., et al. Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy. EMBO J 21 8 (2002 Apr 15) 1939-1947
13. Baluk P., Lee C.G., Link H., Ator E., Haskell A., Elias J.A., et al. Regulated angiogenesis and vascular regression in mice overexpressing vascular endothelial growth factor in airways. Am J Pathol 165 4 (2004) 1071-1085
14. Baffert F., Le T., Sennino B., Thurston G., Kuo C.J., Hu-Lowe D., et al. Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling. Am J Physiol Heart Circ Physiol 290 2 (2006) H547-H559
15. Bezuidenhout D., Davies N., and Zilla P. Effect of well defined dodecahedral porosity on inflammation and angiogenesis. ASAIO J 48 5 (2002) 465-471
16. Thurston G., Baluk P., Hirata A., and McDonald D. Permeability-related changes revealed at endothelial cell borders in inflamed venules by lectin binding. Am J Physiol 271 6 Pt 2 (1996) H2547-H2562
17. Beckstead J. A simple technique for preservation of fixation-sensitive antigens in paraffin-embedded tissues. J Histochem Cytochem 42 8 (1994) 1127-1134
18. Gosain A., Matthies A.M., Dovi J.V., Barbul A., Gamelli R.L., and DiPietro L.A. Exogenous pro-angiogenic stimuli cannot prevent physiologic vessel regression. J Surg Res 135 2 (2006) 218-225
19. Makanya A.N., Hlushchuk R., Baum O., Velinov N., Ochs M., and Djonov V. Microvascular endowment in the developing chicken embryo lung. Am J Physiol Lung Cell Mol Physiol 292 5 (2007) L1136-L1146
20. Chan-Ling T., Page M.P., Gardiner T., Baxter L., Rosinova E., and Hughes S. Desmin ensheathment ratio as an indicator of vessel stability: evidence in normal development and in retinopathy of prematurity. Am J Pathol 165 4 (2004) 1301-1313
21. Benjamin L., Hemo I., and Keshet E. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125 9 (1998) 1591-1598
22. Matsumoto M., Tanaka T., Yamamoto T., Noiri E., Miyata T., Inagi R., et al. Hypoperfusion of peritubular capillaries induces chronic hypoxia before progression of tubulointerstitial injury in a progressive model of rat glomerulonephritis. J Am Soc Nephrol 15 6 (2004) 1574-1581
23. Murohara T., Horowitz J.R., Silver M., Tsurumi Y., Chen D., Sullivan A., et al. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Circulation 97 1 (1998) 99-107
24. Schmetterer L., and Polak K. Role of nitric oxide in the control of ocular blood flow. Prog Retin Eye Res 20 6 (2001) 823-847
25. Peirce S.M., Price R.J., and Skalak T.C. Spatial and temporal control of angiogenesis and arterialization using focal applications of VEGF164 and Ang-1. Am J Physiol Heart Circ Physiol 286 3 (2004) H918-H925